Blog

IONIQ Sciences / Awards and Recognition  / IONIQ is “Best Diagnostic Testing Solution 2023”

IONIQ is “Best Diagnostic Testing Solution 2023”

Salt Lake City, UT, July 7, 2023Medtech Breakthrough has awarded IONIQ Sciences the “Best Diagnostic Testing Solution of 2023″ (link). Our mission is to “break through” the screening status quo to catch cancer early. You and your doctor could know in just 20 minutes with no needles, no radiation, and no surgery.

Watch this video to learn how we’re modernizing early stage cancer detection (link) and listen to Mr. Jared Bauer, CEO, explain it on a recent episode of the Empowered Patient podcast (link)

About IONIQ Sciences, Inc.

IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA.

About BioHive

IONIQ Sciences is proud to be a key supporter and member of the newly formed BioHive, a collective representing the life science and healthcare innovation ecosystem. By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America and their innovations are improving the lives of millions of patients. To learn more, please visit: https://www.biohive.com

For further information about IONIQ Sciences, Inc., please contact:
Andy Robertson | 1-801-736-0729 | acr@IONIQsciences.com
IONIQ Sciences, Vice President of Business Development

IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA

www.IONIQsciences.com

Follow IONIQ Sciences, Inc. on Instagram, TwitterFacebook and LinkedIn: @IONIQSciences